Literature DB >> 8270133

Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.

M I Uusitupa1, L K Niskanen, O Siitonen, E Voutilainen, K Pyörälä.   

Abstract

The purpose of the present study was to examine 10-year cardiovascular morbidity and mortality in patients with newly-diagnosed Type 2 (non-insulin-dependent) diabetes mellitus and non-diabetic control subjects and to evaluate the effects of general risk factors, plasma insulin, urinary albumin excretion, lipoprotein abnormalities characteristic of Type 2 diabetes and the degree of hyperglycaemia in diabetic patients on cardiovascular mortality. Furthermore, the extent to which the above-mentioned factors could contribute to the excessive cardiovascular mortality observed in diabetic patients was examined. In the years 1979-1981, altogether 133 (70 men, 63 women) newly-diagnosed patients with Type 2 diabetes and 144 (62 men, 82 women) non-diabetic control subjects aged 45-64 years were studied. Both groups were re-examined in the years 1985-1986 and 1991-1992. The impact of different factors on cardiovascular mortality was examined by univariate analyses after adjustment for age and sex and by multiple logistic regression analyses. The age-standardized total and cardiovascular mortality rates were substantially higher in diabetic men (17.8 and 15.0%, total and cardiovascular mortality, respectively p = 0.06 and NS) and women (18.5 and 16.6%, p < 0.01 for both) than in non-diabetic control men (5.2% both total and cardiovascular mortality) and women (4.2 and 2.2%). Cardiovascular mortality was not related to the treatment modality (diet, oral drugs, insulin) at 5 years from diagnosis. Use of diuretics, beta-blocking agents or their combination at baseline did not make a significant contribution to cardiovascular mortality either. In multiple logistic regression analysis on diabetic patients, age, LDL triglycerides, smoking, blood glucose and ischaemic ECG at baseline had independent associations with cardiovascular mortality. Interestingly, urinary albumin excretion rate measured at 5-year examination also predicted 10-year cardiovascular mortality after adjustment for the effects of major risk factors including lipoprotein abnormalities, but its predictive power reduced to a nonsignificant level when the effect of plasma glucose was taken into account. The relative risk of cardiovascular mortality associated with diabetes was 8.2 after allowing for age alone, but it declined to 3.7 when all contributing factors from the baseline examination (except blood glucose) were taken into account. In conclusion, the present results indicate that LDL triglycerides and/or other changes in lipoprotein composition characteristic of Type 2 diabetes and manifesting as elevated serum triglycerides are atherogenic and they strongly predict increased cardiovascular mortality.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8270133     DOI: 10.1007/bf00401063

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  49 in total

Review 1.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

2.  Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects.

Authors:  L K Niskanen; M I Uusitupa; H Sarlund; O Siitonen; K Pyörälä
Journal:  Diabetes Care       Date:  1990-01       Impact factor: 19.112

3.  A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.

Authors:  J E Manson; G A Colditz; M J Stampfer; W C Willett; A S Krolewski; B Rosner; R A Arky; F E Speizer; C H Hennekens
Journal:  Arch Intern Med       Date:  1991-06

4.  Downregulation of high-density lipoprotein receptor in human fibroblasts by insulin and IGF-I.

Authors:  M J Oppenheimer; K Sundquist; E L Bierman
Journal:  Diabetes       Date:  1989-01       Impact factor: 9.461

Review 5.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

6.  Clinical macrovascular disease in Caucasoid diabetic subjects: logistic regression analysis of risk variables.

Authors:  T A Welborn; M Knuiman; V McCann; K Stanton; I J Constable
Journal:  Diabetologia       Date:  1984-12       Impact factor: 10.122

7.  High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes.

Authors:  E Standl; H U Janka
Journal:  Horm Metab Res Suppl       Date:  1985

8.  Low-density lipoprotein subclass patterns and risk of myocardial infarction.

Authors:  M A Austin; J L Breslow; C H Hennekens; J E Buring; W C Willett; R M Krauss
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

9.  The maintenance of improved metabolic control after intensified diet therapy in recent type 2 diabetes.

Authors:  M Uusitupa; J Laitinen; O Siitonen; E Vanninen; K Pyörälä
Journal:  Diabetes Res Clin Pract       Date:  1993-03       Impact factor: 5.602

10.  Hyperinsulinaemia is not a major coronary risk factor in elderly men. The study of men born in 1913.

Authors:  L Welin; H Eriksson; B Larsson; L O Ohlson; K Svärdsudd; G Tibblin
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

View more
  46 in total

Review 1.  Is it possible to predict diabetic kidney disease?

Authors:  S M Thomas; G C Viberti
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

2.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

3.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.

Authors:  A I Adler; I M Stratton; H A Neil; J S Yudkin; D R Matthews; C A Cull; A D Wright; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

4.  Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin.

Authors:  T Nakagami
Journal:  Diabetologia       Date:  2004-02-18       Impact factor: 10.122

5.  Losartan and simvastatin inhibit platelet activation in hypertensive patients.

Authors:  Shosaku Nomura; Akira Shouzu; Seitarou Omoto; Mitsushige Nishikawa; Shirou Fukuhara; Toshiji Iwasaka
Journal:  J Thromb Thrombolysis       Date:  2004-12       Impact factor: 2.300

6.  Elevated circulating adhesion molecules in NIDDM--potential mediators in diabetic macroangiopathy.

Authors:  P Fasching; W Waldhäusl; O F Wagner
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

Review 7.  Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice.

Authors:  S Vijan; D L Stevens; W H Herman; M M Funnell; C J Standiford
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

Review 8.  Diagnosis of CAD in patients with diabetes: who to evaluate.

Authors:  Lawrence H Young; Powell Jose; Deborah Chyun
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

9.  Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial.

Authors:  Matti Uusitupa; Markku Peltonen; Jaana Lindström; Sirkka Aunola; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Timo T Valle; Johan G Eriksson; Jaakko Tuomilehto
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

10.  Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study.

Authors:  Maryam Tohidi; Masumeh Hatami; Farzad Hadaegh; Maryam Safarkhani; Hadi Harati; Fereidoun Azizi
Journal:  Lipids Health Dis       Date:  2010-01-23       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.